Market Cap

Genus plc Market Capitalization:

£1.69 Billion

GBP as of Jan. 1, 2026

US$2.27 Billion

business Genus plc Company Profile

Genus plc Main Stock Listing

LSE: GNS

Market Capitalization History of Genus plc

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $158.96 B
Vertex Pharmaceuticals Incorporated $115.92 B
CSL Limited $95.75 B
Regeneron Pharmaceuticals, Inc. $82.28 B
Marinomed Biotech AG $70.11 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $968.50 B
Johnson & Johnson $499.57 B
AbbVie $405.28 B
Roche $332.12 B
UnitedHealth Group $304.72 B

Yearly evolution of Genus plc market cap

Date Market Cap YoY Change
Jan. 1, 2026 £1.69 B 43.37%
Jan. 1, 2025 £1.18 B -17.72%
Jan. 1, 2024 £1.43 B -30.49%
Jan. 1, 2023 £2.06 B -19.36%
Jan. 1, 2022 £2.56 B -22.82%
Jan. 1, 2021 £3.31 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

Genus plc Categories

United Kingdom languages Healthcare languages Biotechnology
United Kingdom Healthcare United Kingdom Biotechnology

Stocks & Indices

Genus plc has the following listings and related stock indices.


Stock: LSE: GNS

Stock: FSX: GBE

Stock: OTC: GENSF

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.